Compare SSD & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SSD | ICLR |
|---|---|---|
| Founded | 1956 | 1990 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.4B | 7.1B |
| IPO Year | 1996 | 2001 |
| Metric | SSD | ICLR |
|---|---|---|
| Price | $175.01 | $96.99 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 13 |
| Target Price | ★ $206.00 | $182.08 |
| AVG Volume (30 Days) | 189.7K | ★ 1.4M |
| Earning Date | 04-27-2026 | 04-29-2026 |
| Dividend Yield | ★ 0.65% | N/A |
| EPS Growth | ★ 8.42 | N/A |
| EPS | ★ 8.24 | N/A |
| Revenue | ★ $2,332,808,000.00 | N/A |
| Revenue This Year | $3.82 | N/A |
| Revenue Next Year | $5.57 | N/A |
| P/E Ratio | $21.24 | ★ $12.91 |
| Revenue Growth | ★ 4.51 | N/A |
| 52 Week Low | $137.35 | $66.57 |
| 52 Week High | $211.98 | $211.00 |
| Indicator | SSD | ICLR |
|---|---|---|
| Relative Strength Index (RSI) | 28.60 | 33.69 |
| Support Level | $174.83 | $66.57 |
| Resistance Level | $187.60 | $113.88 |
| Average True Range (ATR) | 4.36 | 4.52 |
| MACD | -1.97 | 1.62 |
| Stochastic Oscillator | 0.51 | 5.54 |
Simpson Manufacturing Co Inc designs, manufactures, and markets systems and products to make buildings and structures safe and secure. It produces wood construction products, including connectors, truss plates, fastening systems, fasteners, and shearwalls, as well as concrete construction products such as adhesives, specialty chemicals, mechanical anchors, powder actuated tools, and fiber reinforcing materials. The company serves residential, industrial, commercial, and infrastructure construction, remodeling, and do-it-yourself markets, operating exclusively in the building products industry. It has three regional segments: North America, Europe, and Asia/Pacific. The majority of its revenue comes from wood products.
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.